Pretreatment time with norbinaltorphimine

Anesth Analg. 2010 Apr 1;110(4):1243-4; author reply 1244. doi: 10.1213/ANE.0b013e3181ced654.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer / pharmacology
  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / antagonists & inhibitors
  • Analgesics, Opioid / therapeutic use*
  • Animals
  • Injections, Intraventricular
  • Injections, Spinal
  • Ischemic Preconditioning, Myocardial*
  • Morphine / administration & dosage
  • Morphine / antagonists & inhibitors
  • Morphine / therapeutic use*
  • Naltrexone / analogs & derivatives*
  • Naltrexone / therapeutic use
  • Narcotic Antagonists / therapeutic use*
  • Rats
  • Receptors, Opioid, delta / agonists
  • Receptors, Opioid, kappa / agonists
  • Receptors, Opioid, mu / agonists

Substances

  • Analgesics, Opioid
  • Narcotic Antagonists
  • Receptors, Opioid, delta
  • Receptors, Opioid, kappa
  • Receptors, Opioid, mu
  • norbinaltorphimine
  • Naltrexone
  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
  • Morphine